Teva Must Face Bulk Of Asthma Inhaler Antitrust Suit
A Massachusetts federal judge largely refused Tuesday to toss antitrust claims accusing Teva of a decadelong anticompetitive scheme to delay generic competition for its blockbuster QVAR asthma inhalers, finding it plausible...To view the full article, register now.
Already a subscriber? Click here to view full article